Depending on one’s perspective, the anti-inflammatory colchicine is either an unsung and underprescribed drug for patients with cardiovascular disease, or it’s an agent with limited clinical benefit ...

Study finds that fewer patients with gout received useful colchicine drug after FDA actions led to 50x increase in price. Well intentioned, but costly and potentially problematic. That's how ...